206APRISM BioLab Co.,LTD¥ --

PRISM BioLab Co.,LTD

206A

TSE PrimePharmaceuticals

¥ -

View detailed cash flow statement data.

paymentsCash Flow (CF) Summary

Updated: 2026/03/31FY2026 Q2

Operating CF

-4.6B JPY

YoY +33.6%

Investing CF

-15.4B JPY

YoY -8270.8%

Financing CF

1730.3M JPY

YoY -40.5%

Free CF

-20B JPY

YoY -179.5%

Cash Flow Trend (5 Years)

Investing CF

Operating CF

Financing CF

33.7億0

-14.7億

0000

1.5億

33.7億

-2.4億

2024

3359万

-6901万

-14.7億

2025

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

16.9億8.4億0-8.4億-16.9億

20242025

waterfall_chartCash Flow Bridge (FY2025 Annual)

Beginning / Ending

Increase

Decrease

50億43.8億37.5億31.3億25億

44.2億

Opening Cash

-14.7億

Operating CF

-6901万

Investing CF

3359万

Financing CF

Other

29.2億

Closing Cash

Cash Flow Statement

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan